Gregory Hundemer profile picture

Contact Information

Gregory Hundemer, MD, MPH
6137388400 x82716
ghundemer@toh.ca

Gregory Hundemer

Associate Scientist, Clinical Epidemiology Program
Ottawa Hospital Research Institute
Assistant Professor, Medicine
University of Ottawa
Staff Nephrologist
The Ottawa Hospital

Research Interests

Dr. Hundemer's research interests focus on resistant forms of hypertension. In particular, he is interested in the pathophysiology of both overt and subclinical forms of aldosterone excess, how to identify these patients, and treatment strategies to improve their long-term health outcomes.

Brief Biography

Dr. Hundemer is an Associate Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute, an Assistant Professor of Medicine at the University of Ottawa, and a staff nephrologist at the Ottawa Hospital. He received his M.D. from Vanderbilt University (2007) and M.P.H. from Johns Hopkins University (2011). Following medical school, he served 4 years as a flight surgeon in the United States Air Force. He then completed his internal medicine residency at Massachusetts General Hospital (2015) and nephrology fellowship at the combined Massachusetts General Hospital and Brigham & Women’s Hospital Joint Nephrology Fellowship Program (2018).

Selected Publications

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018; 6(1):51-9.

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Incidence of atrial fibrillation and mineralocorticoid receptor activity in medically and surgically treated primary aldosteronism. JAMA Cardiology. 2018; 3(8):768-74.

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Renal outcomes in medically and surgically treated primary aldosteronism. Hypertension. 2018; 72(3):658-66.

Hundemer GL, Baudrand R, Brown JM, Curhan G, Williams GH, Vaidya A. Renin phenotypes characterize vascular disease, autonomous aldosteronism, and mineralocorticoid receptor activity. J Clin Endocrinol Metab. 2017; 102(6):1835-43.

Baudrand R, Guarda FJ, Fardella C, Hundemer G, Brown J, Williams G, Vaidya A. Continuum of renin-independent aldosteronism in normotension. Hypertension. 2017; 69(5):950-6.

Diseases, conditions and populations of interest


Heart disease; Kidney disease; Vascular, heart and metabolic disease



Research and clinical approaches


Biomarkers; Clinical research; Cohort studies